RCT | No benefit from a model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients.

Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial – Intensive Care Medicine

Commentary on Twitter

Individualising beta-lactam ABTs/ciprofoxacin therapy in #ICU using model-informed precision dosing vs standard dosing, multicentre ?? RCT
No evidence for clinical effect of MIPD on LOS or other secondary outcomes in critically ill pts#FOAMcc @yourICM
?️https://t.co/6HzLBBnFdU pic.twitter.com/uErsHNAV5p

— Intensive Care Medicine (@yourICM) November 9, 2022